SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Merck & Co Inc

Merck is trending as investors speculate on potential buyout targets like Sellas Life Sciences and Inhibrx to help the pharmaceutical giant navigate the upcoming patent cliff for its flagship cancer drug, Keytruda. The community is heavily focused on the competitive dynamics of oncology platform acquisitions and the high-stakes data readouts expected to shape future merger and acquisition activity in the sector.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and fibre channel storage area networking business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom is trending as investors react to a significant multi-year agreement with Apple to develop and supply custom ASIC silicon products through 2031, providing the company with long-term revenue visibility. Community discussions are highly focused on this deal as a major catalyst that reinforces Broadcom's central role in the AI infrastructure and semiconductor supply chain.

PENGU is the official coin of Pudgy Penguins.  Pudgy Penguins has become the face of crypto with one of the most influential communities in the industry. From large companies wearing the Penguin, to being featured in ETF commercials, to garnering millions of followers and over 100 billion views, the Pengu has become a cultural icon making PENGU the world’s social currency.  PENGU allows for the ever-expanding Pudgy Penguin fanbase and the hundreds of millions of people outside of crypto that see and share the Pudgy Penguin everyday, to join The Huddle. PENGU is a symbol for community, memes, and good vibes.  Believe in Pengu. Believe in the Prophecy.

Pudgy Penguins

Pudgy Penguins is trending as investors debate its long-term potential, weighing concerns over recent price stagnation against the project's real-world revenue from physical merchandise and brand initiatives. Community members are actively discussing the token's value proposition relative to established meme coins, with many focusing on accumulation strategies despite market volatility.

iShares Trust - iShares Russell 2000 Index Fund

iShares Russell 2000 ETF

The Russell 2000 ETF is currently experiencing heightened volatility and intense debate as traders weigh potential small-cap rotation against broader macro risks like interest rate uncertainty and geopolitical tensions. While some investors are banking on a bullish breakout fueled by index reshuffling and broadening leadership, others are actively hedging or betting on a downturn, citing elevated leverage and the historical tendency for small caps to struggle in high-rate environments.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

SPY is currently facing volatility as investors weigh escalating geopolitical tensions in the Strait of Hormuz against ongoing corporate earnings reports and institutional market manipulation. Community discussions are split between those betting on a short-term dip due to energy risks and those anticipating a swift recovery driven by recurring peace deal narratives and institutional buying.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Sellas Life Sciences is experiencing significant social sentiment and institutional interest, driven by anticipation surrounding the REGAL trial's final survival events and persistent buyout rumors involving major pharmaceutical players. Investors are actively debating the timing of topline data, the impact of potential institutional accumulation, and the stock's valuation as they wait for conclusive trial results.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

The United States Oil Fund is trending due to renewed geopolitical instability in the Middle East, specifically reports of Iranian aggression in the Strait of Hormuz and a subsequent U.S. crackdown on Iranian oil export licenses. Market participants are actively debating whether these tensions signify a return to sustained military conflict or if the price volatility is a temporary response to headline-driven news and ongoing market manipulation.

Zcash is a privacy-focused cryptocurrency that uses trustless zero-knowledge proofs to enable fully encrypted transactions while maintaining blockchain transparency and security. It was the first cryptocurrency to implement zero-knowledge encryption for private peer-to-peer payments, addressing the fundamental privacy gap in traditional cryptocurrencies that expose transaction details publicly.   With a fixed supply of 21 million ZEC and a halving schedule similar to Bitcoin, Zcash allows users to prove transactions are valid without revealing sensitive information like wallet balances, transaction amounts, or participant identities, making it suitable for everyday payments, long-term savings, and cross-border money transfers where financial confidentiality matters.  The protocol operates on its own blockchain currently using Proof-of-Work consensus, though it's evolving toward Proof-of-Stake through the planned "Crosslink" upgrade to enhance security, scalability, and energy efficiency. Zcash employs trustless zero-knowledge proofs (Halo) within its Orchard shielded pool to verify transactions without revealing sender, receiver, or amount information.   Users can choose between transparent public transactions and shielded private transactions through Unified Addresses, which work with both types. The network is faster and cheaper than Bitcoin, with new blocks mined every 75 seconds and transaction fees typically just a fraction of a cent. Privacy adoption has surged in 2025, with over 30% of total ZEC supply now held in fully shielded pools.  Zcash was created by a group of scientists in 2013 who initially proposed Zerocoin as a privacy extension to Bitcoin before building a standalone protocol. The ecosystem operates with a self-funded development model where block rewards support independent teams through the Zcash Community Grants Committee and a new Coinholder-Controlled Fund.

Zcash

Zcash is facing intense volatility following the discovery of a critical privacy-related bug, sparking widespread community debate over supply integrity and the long-term viability of hidden-ledger assets. While some traders view the price dip as a strategic entry point and a validation of the protocol's improved security, others are liquidating positions, citing broken trust and the inability to verify if the vulnerability was exploited.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

Investors are closely monitoring escalating geopolitical tensions in the Strait of Hormuz, as the market weighs the impact of renewed airstrikes and potential energy disruptions against high expectations for upcoming earnings. Community sentiment is deeply divided, with many traders debating whether recent index strength represents a resilient bull market or a temporary consolidation before a significant rotation.

Enphase Energy, Inc. is a global energy technology company, which engages in the business of designing, developing, manufacturing, and selling home energy solutions that manage energy generation, energy storage, control, and communications on one intelligent platform. It operates through the following geographical segments: the United States, the Netherlands, and Others. The company was founded by Raghuveer R. Belur and Martin Fornage in March 2006 and is headquartered in Fremont, CA.

Enphase Energy Inc

Enphase Energy is attracting intense community interest as investors weigh its potential as an AI-linked infrastructure play, particularly regarding its new solid-state transformer technology for data centers. While some remain cautious due to historical volatility and lingering residential solar headwinds, bullish sentiment is building around the stock's potential for a major recovery cycle driven by shifts in energy demand and domestic policy.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

PRIME SUBGROUP ANALYSIS DEMONSTRATES 22% REDUCTION IN NICU ADMISSIONS IN FIRST-TIME PREGNANCIES USING PreTRM Test-GUIDED CARE

PRIME SUBGROUP ANALYSIS DEMONSTRATES 22% REDUCTION IN NICU ADMISSIONS IN FIRST-TIME PREGNANCIES USING PreTRM Test-GUIDED CARE PRIME SUBGROUP ANALYSIS DEMONSTRATES 22% REDUCTION IN NICU ADMISSIONS IN FIRST-TIME PREGNANCIES USING PreTRM Test-GUIDED CARE PR Newswire SALT LAKE CITY, July 9, 2026...

SERA PROGNOSTICS ANNOUNCES APPOINTMENT OF MARK CAPONE TO ITS BOARD OF DIRECTORS

SERA PROGNOSTICS ANNOUNCES APPOINTMENT OF MARK CAPONE TO ITS BOARD OF DIRECTORS SERA PROGNOSTICS ANNOUNCES APPOINTMENT OF MARK CAPONE TO ITS BOARD OF DIRECTORS PR Newswire SALT LAKE CITY, June 30, 2026 SALT LAKE CITY, June 30, 2026 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company...

SERA PROGNOSTICS COLLABORATES ON ARPA-H AWARD TO ADVANCE POINT-OF-CARE DIAGNOSTIC FOR SAFER BIRTH

SERA PROGNOSTICS COLLABORATES ON ARPA-H AWARD TO ADVANCE POINT-OF-CARE DIAGNOSTIC FOR SAFER BIRTH SERA PROGNOSTICS COLLABORATES ON ARPA-H AWARD TO ADVANCE POINT-OF-CARE DIAGNOSTIC FOR SAFER BIRTH PR Newswire SALT LAKE CITY, June 24, 2026 SALT LAKE CITY, June 24, 2026 /PRNewswire/ -- Sera...

SERA APPLAUDS ILLINOIS INITIATIVE TO EXPAND MEDICAID COVERAGE FOR PROTEOMIC BLOOD TESTING IN PREGNANCY

SERA APPLAUDS ILLINOIS INITIATIVE TO EXPAND MEDICAID COVERAGE FOR PROTEOMIC BLOOD TESTING IN PREGNANCY SERA APPLAUDS ILLINOIS INITIATIVE TO EXPAND MEDICAID COVERAGE FOR PROTEOMIC BLOOD TESTING IN PREGNANCY PR Newswire SALT LAKE CITY, June 23, 2026 --Aligns With Growing Focus on Early Identification...

All You Need to Know About Sera Prognostics (SERA) Rating Upgrade to Buy

Sera Prognostics (SERA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

SERA PROGNOSTICS ANNOUNCES BOARD TRANSITION

SERA PROGNOSTICS ANNOUNCES BOARD TRANSITION SERA PROGNOSTICS ANNOUNCES BOARD TRANSITION PR Newswire SALT LAKE CITY, June 1, 2026 SALT LAKE CITY, June 1, 2026 /PRNewswire/ --Sera Prognostics Inc., The Pregnancy Company (Nasdaq: SERA), focused on improving maternal and neonatal health by providing...

Sera Prognostics (SERA) Loses 27% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Sera Prognostics (SERA) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

Sera Prognostics (NASDAQ:SERA) Releases Quarterly Earnings Results, Misses Estimates By $0.01 EPS

Sera Prognostics (NASDAQ:SERA - Get Free Report) issued its quarterly earnings results on Wednesday. The company reported ($0.17) earnings per share (EPS) for the quarter, missing analysts' consensus...

Sera Prognostics, Inc. (SERA) Reports Q1 Loss, Misses Revenue Estimates

Sera Prognostics (SERA) delivered earnings and revenue surprises of -6.25% and -90.35%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

SERA PROGNOSTICS REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS

SERA PROGNOSTICS REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS SERA PROGNOSTICS REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS PR Newswire SALT LAKE CITY, May 6, 2026 SALT LAKE CITY, May 6, 2026...

Sera Prognostics, Inc. engages in the provision of personalized diagnostics to predict and manage pregnancy complications. It focuses on developing blood tests to predict the risks of preterm birth, preeclampsia and other pregnancy complications. The company was founded by Steven W. Graves, Dennis Farrar and M. Sean Esplin in 2008 and is headquartered in Salt Lake City, UT.

Sera Prognostics Inc - Ordinary Shares Class A

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$1.97
Prev Close	$2.06
Open	$2.04
Dividend Yield	0.00%
50-Day Moving Average	$1.93
Beta	0.81
Avg. Volume	46,280.42
PE Ratio	-3.05

52-Week High	$3.95
52-Week Low	$1.56
Market Capitalization	$77.14M
EPS (Annual)	-$0.6699
Price to Book	1.14
Revenue Per Employee	$1,125.00

Feed

News

Sentiment

Earnings

Fundamentals

Info

SERASera Prognostics Inc

Latest SERA News